DAY OF DIALOGUE
on Public-Sector Pricing of Pharmaceutical Products
For decades, patients, doctors, ethicists, and other observers have debated the economics of the pharmaceutical industry. What is the best way to get medications to the people who need them, regardless of their ability to pay for these drugs? Can prices can be lowered without jeopardizing basic research for new drugs? Are drug company pricing practices monopolistic? What are the legal and ethical obligations related to drugs developed—partially or fully—with public funds?
The Population Council convened a daylong meeting of an eminent group of academics and scientists; representatives from the nonprofit sector, the pharmaceutical industry, foundations, and government donor agencies; and practicing lawyers and doctors—all of whom have some connection with pharmaceutical products. The purpose of the Day of Dialogue was to explore ways of getting medicinal products—especially those invented and developed partially or fully using public funding—into the hands of the poor people of the world, wherever they live.
The report of this October 2005 meeting is now available online. (PDF)
This Day of Dialogue publication is distributed without charge. Information in this report may be reproduced without permission, provided it is distributed without charge and the source is acknowledged.
See Also
"The Population Council joins forces with Schering to establish the International Contraceptive Access Foundation" (2004) (news release)
 Print this page | This page updated |